Santosh Vetticaden Insider Trading
Get free email notifications about insider trading for Santosh Vetticaden.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Santosh Vetticaden. Santosh Vetticaden is a SVP, Chief Medical Officer *** in DEPOMED INC ($DMI) and a Chief Medical Officer in MAXYGEN INC ($MAXY) and a Senior Vice President in MAXYGEN INC ($MAXY) and a Interim CEO in Insys Therapeutics, Inc. ($INSY) and a Interim CEO and CMO in Insys Therapeutics, Inc. ($INSY).
Address: C/O MAXYGEN, INC. 515 GALVESTON DRIVE REDWOOD CITY 94063 CA
Companies in which Santosh Vetticaden is an Insider
Assertio Therapeutics, Inc
Trading Symbol: DMIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Santosh Vetticaden: SVP, Chief Medical Officer ***
Holdings: 0 shares
Latest Transaction: Feb 08 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Insys Therapeutics, Inc.
Trading Symbol: INSYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Santosh Vetticaden: Interim CEO and CMO, Interim CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 23 2017
$INSY Market Capitalization: $694.73M
$INSY Previous Close: $9.96
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MAXYGEN INC
Trading Symbol: MAXYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Santosh Vetticaden: Chief Medical Officer, Senior Vice President
Holdings: 100,000 shares
Latest Transaction: Jul 03 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Santosh Vetticaden
Sentiment: All, DMI, INSY, MAXY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2018 | DMI | DEPOMED INC | Vetticaden Santosh | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 36,800 | 0 | 36,800 | |
Oct 18 2017 | DMI | DEPOMED INC | Vetticaden Santosh | SVP, Chief Medical ... | Option Exercise | A | 0.00 | 53,325 | 0 | 53,325 | |
Oct 18 2017 | DMI | DEPOMED INC | Vetticaden Santosh | SVP, Chief Medical ... | Option Exercise | A | 5.06 | 109,343 | 553,276 | 109,343 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO and CMO | Option Exercise | A | 0.00 | 14,000 | 0 | 14,000 | |
Feb 23 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO and CMO | Option Exercise | A | 12.65 | 56,000 | 708,400 | 56,000 | |
Jan 17 2017 | INSY | Insys Therapeutics ... | Vetticaden Santosh | Interim CEO | Option Exercise | A | 10.39 | 30,000 | 311,700 | 30,000 | |
Jul 03 2008 | MAXY | MAXYGEN INC | Vetticaden Santosh | Chief Medical Offic ... | Option Exercise | A | 3.51 | 25,000 | 87,750 | 25,000 |